rs140183285

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020987.5(ANK3):​c.9997A>T​(p.Thr3333Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00226 in 1,614,070 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 5 hom. )

Consequence

ANK3
NM_020987.5 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 6.17
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016003609).
BP6
Variant 10-60070884-T-A is Benign according to our data. Variant chr10-60070884-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 434156.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00175 (266/152344) while in subpopulation AMR AF= 0.0034 (52/15306). AF 95% confidence interval is 0.00266. There are 1 homozygotes in gnomad4. There are 133 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.9997A>T p.Thr3333Ser missense_variant Exon 37 of 44 ENST00000280772.7 NP_066267.2 Q12955-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.9997A>T p.Thr3333Ser missense_variant Exon 37 of 44 1 NM_020987.5 ENSP00000280772.1 Q12955-3

Frequencies

GnomAD3 genomes
AF:
0.00175
AC:
267
AN:
152226
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00250
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00164
AC:
411
AN:
250622
Hom.:
1
AF XY:
0.00165
AC XY:
224
AN XY:
135400
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.00290
Gnomad ASJ exome
AF:
0.000497
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000360
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00248
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00232
AC:
3385
AN:
1461726
Hom.:
5
Cov.:
34
AF XY:
0.00226
AC XY:
1644
AN XY:
727174
show subpopulations
Gnomad4 AFR exome
AF:
0.000479
Gnomad4 AMR exome
AF:
0.00262
Gnomad4 ASJ exome
AF:
0.000612
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000348
Gnomad4 FIN exome
AF:
0.000112
Gnomad4 NFE exome
AF:
0.00276
Gnomad4 OTH exome
AF:
0.00219
GnomAD4 genome
AF:
0.00175
AC:
266
AN:
152344
Hom.:
1
Cov.:
32
AF XY:
0.00179
AC XY:
133
AN XY:
74500
show subpopulations
Gnomad4 AFR
AF:
0.000577
Gnomad4 AMR
AF:
0.00340
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00250
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00189
Hom.:
0
Bravo
AF:
0.00184
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00267
AC:
23
ExAC
AF:
0.00166
AC:
201
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00326

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ANK3: BS1 -

not specified Uncertain:1
Aug 22, 2016
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Intellectual disability-hypotonia-spasticity-sleep disorder syndrome Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Sep 15, 2022
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ANK3-related disorder Benign:1
Feb 15, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.35
T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.86
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Uncertain
2.0
M
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.17
Sift
Uncertain
0.0040
D
Polyphen
0.95
P
Vest4
0.50
MutPred
0.31
Gain of relative solvent accessibility (P = 0.09);
MVP
0.65
MPC
0.15
ClinPred
0.040
T
GERP RS
5.5
Varity_R
0.16
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140183285; hg19: chr10-61830642; API